Xibao Yu

6PUBLICATIONS
20CO-AUTHORS
Haematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 06, 2024
BCL11B promotes T-cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis.

Xibao Yu, Yuchen Li, Pengyue Yang

|Jan 18, 2024
Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway.

Xibao Yu, Yan Wang, Jiaxiong Tan

|Jan 15, 2024
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer.

Yuchen Li, Yinfeng Gu, Pengyue Yang

|Jan 28, 2023
High expression of LOC541471, GDAP1, SOD1, and STK25 is associated with poor overall survival of patients with acute myeloid leukemia.

Xibao Yu, Cunte Chen, Yanyun Hu

|May 11, 2022
Correlation of the transcription factors <i>IRF4</i> and <i>BACH2</i> with the abnormal <i>NFATC1</i> expression in T cells from chronic myeloid leukemia patients.

Yikai Zhang, Xiangbo Zeng, Xianfeng Zha

|May 28, 2021
NRF2 activation induced by PML-RARĪ± promotes microRNA 125b-1 expression and confers resistance to chemotherapy in acute promyelocytic leukemia.

Xibao Yu, Ardalan Mansouri, Zhuandi Liu

Pageof 1

Frequent Collaborators

6 joint publications

Yangqiu Li

4 joint publications

Ling Xu

2 joint publications

Chengwu Zeng

2 joint publications

Yikai Zhang